Clinical Outcomes Programs
Receive regular headline summaries whenever high-quality news is generated for Clinical Outcomes Programs. We'll never share your email address with others.
| Shares Healthcare News With (link): | |
|---|---|
| Other Healthcare Entities | We are still establishing shared news links for this healthcare topic. |
Selected Headines
| Date | Headline (link) | Source | Relevant Snippet |
|---|---|---|---|
| 8/31/2020 | Soleo Health Named Preferred Provider by AscellaHealth in the Management of Its Hemophilia Patient Population | Business Wire | FRISCO, Texas- Soleo Health , an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today it was named one of four exclusive providers by AscellaHealth for the care and management of its hemophilia members. AscellaHealth, a national specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, has members spanning more than one million covered lives, including a multitude of hemophilia patients. Effective July 1 ... |
| 8/31/2020 | Soleo Health Named Preferred Provider by AscellaHealth in the Management of Its Hemophilia Patient Population | Business Wire | FRISCO, Texas--(BUSINESS WIRE)--Aug 31, 2020-- Soleo Health , an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today it was named one of four exclusive providers by AscellaHealth for the care and management of its hemophilia members. AscellaHealth, a national specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, has members spanning more than one million covered lives, including a multitude of ... |
| 4/1/2020 | Soleo Health Selected by Grifols as Limited Drug Distribution Partner for XEMBIFY® | Business Wire | FRISCO, Texas--(BUSINESS WIRE)--Apr 1, 2020-- Soleo Health , an innovative national provider of complex specialty pharmacy and infusion services, announced today it has been selected by Grifols , a global healthcare company dedicated to enhancing the health and well-being of people around the world, as one of their specialty pharmacy limited drug distribution providers of XEMBIFY ® (immune globulin subcutaneous human-klhw). This is Grifols’ first 20% immune globulin and ... |
| 11/9/2019 | Hanger, Inc. (HNGR) Vinit Asar on Q3 2019 | Seeking Alpha | ... what I would characterize as a world-class revenue-cycle management organization and believe we are well equipped to respond as needed to these and other similar ordinary course issues as they arise. Our clinical outcomes programs continue to develop by providing us valuable insight into the efficacy of various devices from our different manufacturing partners. We have consistently communicated to them that outcomes matter more today than ever before ... |